Breast Implants Market Trends

Growth Drivers

• Growing demand for reconstructive surgery: The market is remarkably expanding as a result of increasing demand for reconstructive surgery. In this regard, the U.S. FDA in 2023 reports that 40.5% of the total 268,000 breast cancer cases in the U.S. opted for reconstructive surgery, highlighting the post-mastectomy demand. Besides, the AHRQ study in 2022 revealed that early-stage breast reconstruction successfully reduced hospitalization expenses by 23.7% in a span of two years in the U.S.
• Technological progression in implant materials: Both technology and patient safety are positively revolutionizing the breast implants sector.  Exemplifying the same, the 2023 FDA Safety Communication imposed a mandatory strong post-market surveillance, thereby boosting patient confidence. On the other hand, in 2024, Johnson &Johnson announced the launch of MemoryGel BOOST, which is a high-strength silicone implant demonstrating 15.6% low rupture rates, thus denoting a positive market opportunity.

Historical Patient Growth Analysis: Foundation for Future Market Expansion

Historical Patient Growth (2010 - 2020) - Breast Implant Users (Millions)

Feasible Expansion Models Shaping the Future Market

Revenue Feasibility Models (2020 - 2024)

Challenge

• Barriers in governmental pricing strategies: The administrative-imposed pricing strategies have hindered the breast implants market expansion in almost all nations. For instance, in France, CEPS capped implant prices at €853.7, capping manufacturing profits for about 22.5%. Simultaneously, in Germany, G-BA is demanding dual approvals, thereby adding 9 months to 12 months for the product to gain market entry. However, Allergan combated this with hospital bundling deals, hence suitable for market development.